Corvus Pharmaceuticals, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue00000000
Cost of Goods Sold29K26K000000
Gross Profit-29K-26K000000
R&D Expenses11.2M9.9M8.5M7.9M7.5M6.0M5.2M4.1M
Operating Expenses14.9M12.2M10.6M10.3M9.9M8.1M7.3M5.9M
Operating Income-14.9M-12.2M-10.6M-10.3M-9.9M-8.1M-7.3M-5.9M
Other Income / Gains1.2M-104K415K2.3M25.1M-4.0M-33.0M1.7M
Net Income-13.7M-12.3M-10.2M-8.0M15.2M-12.1M-40.2M-4.3M
EPS (Diluted)-0.15-0.18-0.12-0.100.21-0.18-0.60-0.07
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00000000
General And Administrative Expenses3.7M2.3M2.1M2.4M2.5M2.1M2.0M1.8M
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses3.7M2.3M2.1M2.4M2.5M2.1M2.0M1.8M
Other Expenses00000000
Cost And Expenses14.9M12.2M10.6M10.3M9.9M8.1M7.3M5.9M
Interest Income0-1.9M738K639K525K508K566K434K
Interest Expense1.8M0000000
Depreciation And Amortization29K26K28K29K22K20K21K21K
Ebitda-11.9M-12.3M-10.1M-8.0M15.2M-12.1M-40.2M-4.2M
Ebitdaratio00000000
Operating Income Ratio00000000
Income Before Tax-13.7M-12.3M-10.2M-8.0M15.2M-12.1M-40.2M-4.3M
Income Before Tax Ratio00000000
Income Tax Expense00000000
Net Income Ratio00000000
Epsdiluted-0.15-0.18-0.12-0.10-0.13-0.18-0.60-0.07
Weighted Average Shs Out90.0M79.0M82.8M77.8M72.1M68.3M66.7M59.7M
Weighted Average Shs Out Dil90.0M79.7M82.8M77.8M75.2M68.3M66.7M59.7M